Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy
Myotonic dystrophy type 2 (DM2) is a dominantly inherited disorder with multisystemic clinical features, caused by a CCTG repeat expansion in intron 1 of the zinc finger protein 9 (ZNF9) gene. The mutant transcripts are retained in the nucleus forming multiple discrete foci also called ribonuclear i...
Main Authors: | R Cardani, E Mancinelli, V Sansone, G Rotondo, G Meola |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2009-06-01
|
Series: | European Journal of Histochemistry |
Online Access: | https://www.ejh.it/index.php/ejh/article/view/918 |
Similar Items
-
Ribonuclear inclusions as biomarker of myotonic dystrophy type 2, even in improperly frozen or defrozen skeletal muscle biopsies
by: G Meola, et al.
Published: (2009-06-01) -
Ribonuclear inclusions as biomarker of myotonic dystrophy type 2, even in improperly frozen or defrozen skeletal muscle biopsies
by: R Cardani, et al.
Published: (2009-08-01) -
Myotonic dystrophy-2: Unusual phenotype due to a small CCTG-expansion
by: Finsterer J, et al.
Published: (2018-12-01) -
The molecular mechanisms involved in the genetic instability of the CCTG. CAGG repeats associated with myotonic dystrophy type 2
by: Dere, Ruhee J.
Published: (2006) -
Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2
by: R Cardani, et al.
Published: (2009-06-01)